EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anabolic-androgenic steroid use for aesthetic purposes: Long-term endocrine and metabolic repercussions

Júlia Maurício Barreto de Fontes, Tiago Oliveira Abreu Costa, Bruna Soares David, Pedro Lucarelli Gonçalves de Oliveira

International Health Sciences Review · 29.03.2026 · 2 (2)

DOI: 10.70164/ihsr.v2i2.148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Health Sciences Review, online erschienen am 29.03.2026. Verfasst von Júlia Maurício Barreto de Fontes und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The non-medical use of anabolic-androgenic steroids (AAS) has progressively shifted from elite sport into the general population, particularly among men seeking increases in muscularity, leanness, and physical attractiveness rather than competitive advantage. Contemporary surveys and epidemiologic syntheses suggest that this behavior is no longer restricted to professional athletes and should be approached as a relevant public health issue with endocrine, metabolic, cardiovascular, hepatic, reproductive, and psychiatric implications. This review summarizes the long-term consequences of supraphysiological AAS exposure, with special emphasis on the hypothalamic-pituitary-gonadal axis, lipid metabolism, cardiovascular remodeling, liver injury, and the neurobehavioral correlates that sustain recurrent use. A narrative review methodology was structured around studies indexed in PubMed/MEDLINE, Embase, Cochrane Library, and SciELO, prioritizing clinical trials, prospective cohorts, cross-sectional studies with objective phenotyping, and clinically informative case series. The evidence indicates that AAS use can cause profound suppression of gonadotropin secretion, secondary hypogonadism after cessation, delayed spermatogenic recovery, marked reductions in high-density lipoprotein cholesterol, elevations in low-density lipoprotein cholesterol, hypertension, left ventricular hypertrophy, and liver injury that is especially relevant with orally active 17α-alkylated compounds. Recovery after discontinuation is possible in many users, but it is heterogeneous, incomplete in a subset, and insufficiently guided by standardized protocols. The transient aesthetic gains obtained with AAS therefore contrast sharply with the potential for prolonged endocrine morbidity, cardiometabolic injury, and recurrent behavioral dependence, supporting the need for long-term follow-up and better evidence regarding post-cycle interventions.

Zitieren

APA

Fontes, J. M. B. D., Costa, T. O. A., David, B. S., & Oliveira, P. L. G. D. (2026). Anabolic-androgenic steroid use for aesthetic purposes: Long-term endocrine and metabolic repercussions. International Health Sciences Review, 2(2). https://doi.org/10.70164/ihsr.v2i2.148

Vancouver

Fontes JMBD, Costa TOA, David BS, Oliveira PLGD. Anabolic-androgenic steroid use for aesthetic purposes: Long-term endocrine and metabolic repercussions. International Health Sciences Review. 2026;2(2). doi:10.70164/ihsr.v2i2.148

BibTeX
@article{Fontes2026,
  author = {Fontes, Júlia Maurício Barreto de and Costa, Tiago Oliveira Abreu and David, Bruna Soares and Oliveira, Pedro Lucarelli Gonçalves de},
  title = {Anabolic-androgenic steroid use for aesthetic purposes: Long-term endocrine and metabolic repercussions},
  journal = {International Health Sciences Review},
  year = {2026},
  volume = {2},
  number = {2},
  doi = {10.70164/ihsr.v2i2.148}
}
Kostenlos starten →